• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
10th Annual ELNs and Advanced Laboratory Solutions Forum
 

10th Annual ELNs and Advanced Laboratory Solutions Forum

on

  • 623 views

Programme for Pharma IQ's 10th Annual ELNs and Advanced Laboratory Solutions Forum

Programme for Pharma IQ's 10th Annual ELNs and Advanced Laboratory Solutions Forum

Statistics

Views

Total Views
623
Views on SlideShare
622
Embed Views
1

Actions

Likes
0
Downloads
8
Comments
0

1 Embed 1

http://www.docshut.com 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    10th Annual ELNs and Advanced Laboratory Solutions Forum 10th Annual ELNs and Advanced Laboratory Solutions Forum Document Transcript

    • Presents the 10th Annual Europe’s ONLY ELNs event! Register and pay before 27th May 2011 and save up to €600! Two Day Conference: 27th-28th September 2011 Pre-Conference Focus Day & Workshops: 26th September 2011 Venue: Hilton, Barcelona, Spain Hear from over 30 experts including: Tina Spendler Project Manager, NovozymesIncrease productivity, innovation and Michael Elliott CEO, Atrium Research & Consultingcollaboration by implementing the best Markus Duerring IT Account Manager, Novartis InstitutesELNs for your lab for BioMedical Research Jim KingOur expert speaker faculty will show you how to: Director, R&D Business Technology,• Promote interoperability between your ELNs and your facility’s other systems Pfizer Diversified Businesses and instruments with Pfizer and Swedish Orphan Biovitrum Manli Zheng• Select the right ELNs for your lab by determining which functionalities are Senior Group Leader, Scientific Informatics and necessary, which are desirable and which products fulfil your specific needs Automation, Abbott with the help of companies like Lonza and LEO Pharma John Trigg• Explore innovative technologies like the brand-new SharePoint-based Director, phaseFour Informatics system used by Novozymes and assess their applicability to your lab Seth Pinsky• Secure your intellectual property by assessing risks, developing safeguards Director, Scientific Informatics and and complying with regulations under the guidance of Perkins Coie Automation, Abbott• Cultivate the global ELN solutions necessary when outsourcing to CROs and CMOs, testing in developing countries and integrating post-mergers and Julie Spry acquisitions - learn from Abbott’s experience Principal Scientist, Pfizer Colin Sandercock Partner, Perkins Coie LLP Don’t Miss the In-Depth, Interactive Pre-Conference Focus Day and Workshops! Ian Menzies Focus Day Interoperability - It’s Hard to Pronounce and Even Harder to Achieve: Senior Information Manager, AstraZeneca Expediting Your Lab’s Workflow Through Informatics Integration Full speaker panel inside… Workshop A Increasing the Semantic Capabilities of Your ELN to Capture More Complete Data with Jeremy Frey Workshop B Navigating Regulations and Ensuring the Legality of Your IP From the This conference has been R&D Stage Forward with Colin Sandercock valuable, giving me up-to-date information on ELNs & ways to www.elnforum.com improve our system & practices. General Mills SPONSORS & EXHIBITORSCALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com
    • YOuR 2011 EXPERT SPEakER PaNEl Seth Pinsky Ulrik Nicolai de Lichtenberg Director, Scientific Informatics and Automation Head of Research Informatics & Data Management Abbott LEO Pharma Manli Zheng James Sullivan Senior Group Leader, Scientific Informatics Business Excellence Manager and Automation Lonza Custom Manufacturing Mammalian Abbott Division Dominique Vlieghe Markus Duerring Senior Bioinformatician IT Account Manager Ablynx NV Novartis Institutes for BioMedical Research Valentina Cappello Raquel Dias Miranda Discovery Data Management Unit Global Application Service Manager Almirall Novartis Institutes for BioMedical Research Cat Andersen Debra Kassabian Lead Scientific Data Analyst Global Lead Chemistry Information Systems Array BioPharma Novartis Institutes for BioMedical Research Jim Rizzi Tina Spendler Computational Technology Director Project Manager Array BioPharma Novozymes Ian Cooper John Trigg Director Strategy & Portfolio Director phaseFour Informatics AstraZeneca Julie Spry Ian Menzies Principal Scientist Senior Information Manager Pfizer AstraZeneca Jim King, Director Michael Elliott R&D Business Technology CEO Pfizer Diversified Businesses Atrium Research & Consulting Colin Sandercock Jens Koehler Partner Project Manager Perkins Coie LLP BASF SE Bernhard Schirm Pedro Castanheira Managing Director Researcher, Molecular Biology Unit Quattro Research Biocant Torsten Sejlitz Lieselot Bontinck Senior Scientist in Informatics and Automation Senior Research Associate Pharmacology Swedish Orphan Biovitrum Ablynx NV Julia Hadley Morten Meldgaard Senior Business Analyst Project Manager Syngenta Chr. Hansen A/S James Peace Paul Denny-Gouldson Senior Research Chemist Vice President of Translational Medicine Syngenta IDBS Jeremy Frey Danny Verbinnen Professor of Physical Chemistry IT Manager University of Southampton Janssen R&D, Johnson & JohnsonCALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com
    • PRE CONfERENCE fOCuS DaY & WORkSHOPS: 26TH SEPTEmBER 2011 fOCuS DaY: INTEROPERaBIlITY—IT’S HaRD TO PRONOuNCE aND HaRDER TO aCHIEVE Expediting Your lab’s Workflow Through Informatics Integration9.30 Pharma IQ Welcome and Chairperson’s Opening Remarks 11.40 Managing Your Newfound Wealth of Data John Trigg, Director, phaseFour Informatics • Deciding what you need your informatics systems to do: collect, store, transfer, sort, analyse and retrieve data9.40 The Answer’s an ELN: What Was the Question? • Determining which tools offer the greatest usability Facilitating Collaboration Between Your LIMS and Your ELNs • Looking at promising developments (tools, functionalities and • Determining which data belongs in your LIMS and which belongs software) on the horizon and anticipating potential compatibility in your ELN issues • Avoiding redundancies in functionalities or data storage Torsten Sejlitz, Senior Scientist in Informatics and Automation, • Creating collaborative data sharing between your informatics systems Swedish Orphan Biovitrum John Trigg, Director, phaseFour Informatics 12.20 Group Therapy Lunch10.20 Juggling the Informatics Needs of Biology and Chemistry The Triumphs and Tribulations of Integration Laboratories This session is designed to help increase dialogue and knowledge • Identifying the disparate needs of biology and chemistry labs transfer between leading industry experts, solution providers and • Weighing the pros and cons of separate bio and chem ELNs end users. To facilitate this lunchtime learning, the session leader versus one ELN for both purposes will begin with a few suggestions of major challenges related to • Creating an ELN that satisfies the needs of both bio and chem labs interoperability and open the discussion to the audience. The “group or developing the tools necessary for data transfer therapy” learning format opens the lines of communication and is Jim King, Director, R&D Business Technology, Pfizer Diversified designed for speakers, delegates and service providers alike. Businesses Please come prepared to discuss your greatest challenges and11.00 Integrating Via the Web to Create a More Seamless ELN share your successes in the ongoing battle for compatibility among • Creating an innovative new web service layer with a preexisting informatics systems. ELN at Novartis Facilitator: • Streamlining functions such as registration, signing and Seth Pinsky, Director, Scientific Informatics and Automation, Abbott witnessing, analytics requests, assay submissions and more • Expediting data input and transfer without increasing dependency 13.20 Chairperson’s Closing Remarks and End of Focus Day on integration John Trigg, Director, phaseFour Informatics Debra Kassabian, Global Lead Chemistry Information Systems, NIBR Raquel Dias Miranda, Global Application Service Manager, NIBR PRE-CONFERENCE WORKSHOPS: 26TH SEPTEMBER 2011 15.45–16.45 WORkSHOP a Increasing the Semantic Capabilities of Your ElN to Capture more Complete Data There is a growing movement within life-science laboratories to attach a more comprehensive level of semantic information to the data captured within ELNs. This workshop will delve into issues like: • Defining the term semantics as it applies in the laboratory and explaining the importance of semantically rich data capture • Identifying which semantic data your ELN can and should collect and store • Implementing a strategy for collecting semantic annotations at source, using semantic web technology and developing knowledge grids • Utilising semantics to enhance searachability, collaboration and automated processes such as data mining Jeremy Frey, Professor of Physical Chemistry, University of Southampton 17.00–20.00 WORkSHOP B Navigating Regulations and Ensuring the legality of Your IP from the R&D Stage forward Ensuring the safety of your intellectual property is of paramount importance; you need to keep it confidential, compliant with regulations and legally protected. The workshop will cover: • Assessing the current regulations in place in both the US and the EU • Discussing risk-based ELN validation (is it necessary to validate in early research stages?) and identifying the appropriate time to apply authentication methods such as time-stamping and digital signatures • Developing a standard protocol to ensure record integrity and legality in your lab or across your entire company • Creating a long-term data archive that is secure and legally compliant, yet accessible to laboratory personnel Colin Sandercock, Partner, Perkins Coie LLP CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com
    • CONFERENCE DAY ONE: TUESDAY 27TH SEPTEMBER 201108.00 Registration and Coffee 11.00 Networking Coffee Break08.50 Pharma IQ Welcome and Chairperson’s Opening Address, CONFIGURING YOUR INFORMATICS FOR IMPROVED WORKFLOW Michael Elliott, CEO, Atrium Research & Consulting Defining the terms, identifying key challenges and deciding what you need in an ELN DISCUSSING THE STATE OF THE INDUSTRY 11.30 Delineating the Grey Area Between ELNs and LIMS Where are ELNs now, where are they headed and is your lab on track? • Understanding the common definitions of LIMS and ELNs 09.00 Moving Toward an Ideal Future State • Identifying where system functionalities overlap and differ • Examining the ways in which ELNs have improved data management • Following the development of each system and predicting their and operational efficacy and theorising future developments trajectories - will the paths of ELNs and LIMS converge, diverge or • Understanding the data process issues laboratories face and continue to run parallel? identifying how to resolve them using technology such as ELN Markus Duerring, IT Account Manager, NIBR as an enabler 12.10 Creating an Informatics Ecosystem: Promoting a Integrated Lab Programme • Investigating new technologies, their practicality and utility • How Pfizer tackled the challenges of integrating multiple solutions Michael Elliott, CEO, Atrium Research & Consulting (LIMS, ELNs, SDMS, CDS) across two business divisions09.40 Panel Discussion: 10 Years of ELNs - A Look Back (and a Look Forward) • Changing the cultural view of informatics as individual components and • Tracing the progress of ELNs over the last decade as they’ve moved promoting the perception of an intra-organisation informatics ecosystem from novelty to vital laboratory informatics system • Streamlining data input and storage by creating data standards across • Recognising key developments in the field, identifying problem laboratories, departments, your entire company and even external collaborators areas that still exist and contemplating possible solutions Jim King, Director, R&D Business Technology, Pfizer Diversified Businesses • Forecasting future trends and developments - where do ELNs go 12.50 Using an ELN as a Source for Data Warehousing from here? • Moving from the more traditionally structured systems that feed Panellists: John Trigg, Director, phaseFour Informatics data warehouses and incorporating your ELN as a source Jim Rizzi, Computational Technology Director, Array BioPharma • Transferring your data from your ELN and into a warehouse Danny Verbinnen, IT Manager, Janssen R&D, Johnson & Johnson • Efficiently utilising your data in an integrated warehouse Debra Kassabian, Global Lead Chemistry Information Systems, NIBR Bernhard Schirm, Managing Director, Quattro Research10.20 Where ELNS are Heading: Wide, Deep and High 13.05 Networking Lunch Break • Wide – the ever expanding markets for ELNS • Deep – blurring the edges between LIMS and ELN • High – taking ELNS into the cloud Paul Denny-Gouldson, Vice President of Translational Medicine, IDBS STREAM A STREAM B TACkLING PRE- AND EARLY ELN IMPLEMENTATION ISSUES ADDRESSING THE CHALLENGES FACED MID-ELN IMPLEMENTATION TO POST-ROLLOUT14.20 Panel Discussion: Demonstrating the ROI for ELN and Effectively 14.20 Case Study: Developing and Implementing a Global QC Systems Communicating This to Senior Management Strategy to Drive Efficient Laboratory Operation • Building the business case for implementation CASE • Creating a four-tier QC system strategy (SAP-LIMS-ELN-CDS) that • Setting benchmarks and measuring KPIs STUDY drives efficiency and compliance in QC laboratories • Fostering operational excellence through the use of your ELNs • Driving global implementation through process standardisation and Panellists: programme governance Valentina Cappello, Discovery Data Management Unit, Almirall • Examining benefits realised from the approach adopted by AstraZeneca Pedro Castanheira, Researcher, Molecular Biology Unit, Biocant and areas for future development and exploitation James Sullivan, Business Excellence Manager, Lonza Custom Ian Cooper, Strategy & Portfolio Director, AstraZeneca Manufacturing, Mammalian Division 15.00 Effectively Collaborating With External Partners (CROs, CMOs and15.00 Case Study: Ensuring End-User Support for Your ELN Project From Outsourced Testing Facilities) Selection Through Upgrades • Balancing between legal contracts and trust thereby ensuring the CASE • Identifying champions and skeptics within your organisation, security of your IPSTUDY understanding their concerns and (hopefully) converting the naysayers • Planning pragmatically for quick deployment and sustainability while • Drafting a comprehensible, transparent change management strategy capturing partner work details and data in a timely fashion • Incorporating end-user suggestions and feedback from project • Understanding CRO organisations and the local culture inception onward Manli Zheng, Senior Group Leader, Scientific Informatics and James Peace, Senior Research Chemist, Syngenta Automation, Abbott Julia Hadley, Senior Business Analyst, Syngenta15.40 Networking Coffee Break 15.40 Networking Coffee Break16.10 Panel Discussion: Selecting the Best ELN for Your Lab 16.10 Case Study: Implementing a Hybrid (GLP/Non-GLP) ELN at Novartis • Determining your lab’s informatics needs and desires Considering • Ascertaining which is more beneficial: building two separate the available informatics options - do you need both a LIMS and an CASE instances of your ELN or one that can multitask ELN? Only one? Which? STUDY • Ensuring your system meets the needs of different audiences: it • Ensuring your ELN is both backwards-compatible and as future- must comply with health authority regulations for GLP operations proof as possible and it must provide the required flexibility for non-GLP operations Panellists: • Determining the best validation approach to build a system that Ulrik Nicolai de Lichtenberg, Head of Research Informatics & Data stores validated and unvalidated data Management, LEO Pharma Markus Duerring, IT Account Manager, NIBR James Sullivan, Business Excellence Manager, Lonza Custom 16.50 Aligning Your ELN to Your Business - How Far Do You Go? Manufacturing, Mammalian Division COTS, Code, Configuration and Customisation16.50 Validating Your ELNs for GxP Use • Discussing the differences in generic and domain-specific ELNs • Defining validation and understanding its utility and applicability to ELNs • Understanding the consequences of storing data in structured vs. • Guidelines for implementing a ground-up validation program in your facility unstructured formats and developing appropriate templates • Ensuring user comprehension and compliance with GxP methods • Deciding who owns your ELN - how much vendor support Ian Menzies, Senior Information Manager, AstraZeneca do you need and want and how much responsibility does your organisation want to shoulder? Dominique Vlieghe, Senior Bioinformatician, Ablynx NV17.30 Q&A: Ask an End User These are the folks who don’t make the ELNs decisions, but do reap the rewards (or suffer the consequences). Learn how a company’s ELN adoption choices affect system users – what works well, what needs aren’t being met, what discoveries have been made during the adoption process. Get the user input you need before implementing a new ELN or making changes to your existing system! Lieselot Bontinck, Senior Research Associate Pharmacology, Ablynx NV18.00 Chairperson’s Closing Remarks and Close of Day One Michael Elliott, CEO, Atrium Research & Consulting
    • CONFERENCE DAY TWO: WEDNESDAY 28TH SEPTEMBER 201108.30 Registration and Coffee 12.10 Networking Lunch Break08.50 Chairperson’s Opening Address 13.40 Launching an ELN to Humans Michael Elliott, CEO, Atrium Research & Consulting It’s Not Just About the Technology • Making sure that the user - the ultimate consumer for the ELN - ASSESSING NOVEL TECHNOLOGIES AND THEIR APPLICABILITY TO YOUR LAB doesn’t get lost in the implementation process What do they do, who’s using them and which are right for you? • Determining how scientists and other lab personnel will use the ELN • Choosing an ELN that suits the needs of not just your lab, but the 09.00 Case Study: Building an In-House ELN Using a Microsoft SharePoint people who work there Platform James Sullivan, Business Excellence Manager, Lonza Custom • Outlining the rationale behind Novozymes’ decision to create an Manufacturing, Mammalian Division in-house ELN based on SharePoint instead of relying on an off- the-shelf product 14.20 ELN Clinic: Attacking Challenges Head-On • Incorporating significant user group feedback in order to develop Join one of the following roundtables to collaboratively attack a a system that fits the needs of users hypothetical challenge, create a plan of action and solve the • Analysing the benefits (such as enhanced collaboration potential) problem. Scenarios will include: and drawbacks (such as creating additional code) of using • Informatics decisions in the wake of a merger or acquisition SharePoint Facilitator: Julie Spry, Principal Scientist, Pfizer Tina Spendler, Project Manager, Novozymes • Working with an outdated ELN Facilitator: Cat Andersen, Lead Scientific Data Analyst, Array BioPharma EFFECTIVELY UTILISING YOUR ELNS IN NONTRADITIONAL CONTEXTS AND • ELN data warehousing and data mining for discovery TRICKY SITUATIONS Facilitator: Manli Zheng, Senior Group Leader, Scientific Informatics Ensuring your ELN is a help, not a hindrance and Automation, Abbott Choose one of three tables to join!9.40 Case Study: Planning a Successful ELN Implementation at a Food Ingredient Company 15.00 Networking Coffee Break CASE • Ascertaining what needs an ELN must address within a global STUDY food ingredient company and what criteria are paramount within 15.30 Case Study: Implementing an ELN in a Biotherapeutics Pharm Sci the selection process Organisation • Creating and adhering to an aggressive implementation timeline CASE • Testing available ELN solutions to determine suitability for use (while incorporating end user feedback in the process) STUDY in a large-molecules lab • Utilising an ELN as a vehicle for improved knowledge sharing and • Harmonising the needs of the lab with the needs of other moving toward open innovation departments within the company Morten Meldgaard, Project Manager, Chr. Hansen A/S • Encouraging company-wide collaboration and enhancing system and procedural compatibilities10.20 Networking Coffee Break Julie Spry, Principal Scientist, Pfizer10.50 Designing Your ELNs for Reliability and Performance 16.10 Leveraging an ELN to Improve Work Processes in the Lab at BASF • Ensuring the real-time availability of your ELN across all • Improving laboratory workflows • Strengthening information exchange and knowledge sharing geographies (with a minimum of downtime) • Developing methods for successful implementation of an ELN • Achieving an acceptable level of fault tolerance and a reasonable Jens Koehler, Project Manager, BASF SE level of performance • Facilitating communication and collaboration across multiple sites 16.50 Chairperson’s Closing Remarks and Close of Conference (branches and contractors alike) Michael Elliott, CEO, Atrium Research & Consulting Seth Pinsky, Director, Scientific Informatics and Automation, Abbott11.30 Speed Networking, ELNs Edition “ELN is a new area for me. Like Speed Dating, But Without the Pressure to Commit You’ve seen each other across the room…now meet face-to-face. Conference very informative!“ Bring plenty of business cards to exchange in a series of 2-3 minute Nofima Mat AS one-on-one meetings with your fellow speakers, attendees and vendors. Your mission - learn one of the following things about each “A good opportunity to get best person you meet: • What is your biggest ELN challenge? practices in ELN integration.“ • What has been your greatest ELN-related success? L’Oreal • What do you hope to get out of the conference? media Partners
    • SPONSORS AND EXHIBITORS Session Sponsors IDBS is a leading provider of advanced software solutions. IDBS’ applications are integrated data management, analysis and decision-making products used in the drug discovery industry to acquire, manage and use chemical and biological data. IDBS’customers includes the world’s leading pharmaceutical, biotechnological and other discovery research based companies. Website: www.idbs.com Gold Exhibitor Quattro research addresses the needs of life science and chemical industry by providing state-of-the-art solutions to manage all scientific data produced in research projects. Our applications help scientists to optimise the value of their research data, e.g. the electronic lab notebook quattro/LJ or the compound management solution quattro/CM, quattro research offers software and consulting services to build and integrate heterogeneous data sources and applications, such as compound registration, HTS, LIMS or SAP, into efficient and user friendly data management platforms. Website: www.quattro-research.com featured Exhibitors Accelrys, a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. Accelrys’ Enterprise R&D Architecture, built on the industry leading Pipeline PilotTM platform, enables customers to access, organize, analyze and share scientific data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market Website: www.accelrys.com Agilent Technologies is a leading supplier of life science research systems that enable scientists to understand complex biological processes, determine disease mechanisms and speed drug discovery. Engineered for sensitivity, reproducibility and workflow productivity, Agilent’s life science solutions include instrumentation, microfluidics, software, microarrays, consumables and services for genomics, proteomics and metabolomics applications. Website: www.agilent.com CambridgeSoft is a leading provider of software and services for discovery, analysis and collaboration to life sciences and chemical industries, academia and government. Its integrated product suite improves the productivity of researchers in the discovery, development and commercialization of chemical and biological compounds. Products include Cloud, Enterprise, Workgroup and Desktop versions of Chem & Bio Office, including Chem & Bio Draw and E-Notebook, providing knowledge management, chemical and biological informatics and scientific database solutions. Website: www.cambridgesoft.com Contur Software is a focused software company delivering innovative products and services to R&D organizations worldwide. Its proven Electronic Lab Notebook system enables customers to have instant access to their experimental data and results at any time from any location. The system is particularly known for its intuitive graphical user interface and flexible architecture enabling rapid deployments and cost effective operation. iLabber is offered both as an on-premise server based install – iLabber Server – and via a SaaS (Software-as-a-service) model – iLabber Cloud. The iLabber system is used by thousands of users worldwide in the Biotech, Chemical, Food & Beverage and Academic sectors. Website: www.contur.com LabWare is the world’s leading LIMS product used in more than 70 countries worldwide. LabWare LIMS includes an extensive library of “out-of-the-box” features, functions and modules delivering real business advantage for LabWare’s customers. LabWare can now provide a seamlessly integrated experiment and workflow driven ELN designed to give the laboratory scientist the ultimate platform to electronically document their experiments including relevant scientific content and observations, results and attachments such as spectra, chromatograms and, if appropriate, chemical structures. LabWare has invested in providing a truly global support network backed by some of the most experienced LIMS professionals in the world. Website: www.labware.com Sponsorship & Exhibitionmaximise Your Involvement: Sponsorship and Exhibition OpportunitiesPharma IQ’s ElNs & advanced laboratory Solutions is Europe’s long-running and only event dedicated to ELNs and their users. This year’s conferencefeatures two streams catering to individuals at different stages in their ELN implementations: one targeted to organisations in the pre-and earlyimplementation phases and another dedicated to companies in the mid-implementation to post-rollout stages.The conference is attended by key decision-makers - end users who champion ELN projects, IT/IS personnel who facilitate implementation, senior officialswho approve the purchase of systems - bringing together buyers and suppliers together in one place.Focused and high-level, the event will be an excellent platform to initiate new business relationships. With tailored networking, sponsors can achieve theface-to-face contact that overcrowded trade shows cannot deliver.Exhibiting and Sponsorship options are extensive and packages can be tailor-made to suit your company’s needs. Packages include complimentary entrypasses, targeted marketing to industry officials and executives and bespoke networking opportunities.Other features of sponsorship include:• Prominent exhibition space in the main conference networking area• Participation in comprehensive pre-event marketing campaigns• Tailored marketing strategies to suit your organisation’s size, capabilities and individual requirementsFor more information and to discuss the right opportunity, contact Gal Cohen on +44 (0)207 368 9300 or sponsorship@iqpc.co.uk about Pharma IQ Become a member of Pharma IQ and receive complimentary access to resources that will keep you at the forefront of industry change. You will receive access to our growing library of multimedia presentations from industry leaders, an email newsletter updating you on new content that has been added, free aggregated news feed from over 1000 global news sources tracking your industry and special member only discounts on events. Become a member here: www.pharmaceuticaliq.com CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com
    • THE LEADING GLOBAL FORUM FOR ELN AND DATA MANAGEMENT PROFESSIONALSafter a very successful 2010 conference, Pharma IQ’s ElNs event has returned andis celebrating its 10th anniversary. 2011 promises new case studies, two streams of Delegate Profile for Pharma IQ’s ElN forumpresentations targeted at individuals at all stages of implementation and a focus daydesigned to tackle one of the most omnipresent issues in the industry - interoperability.The conference has achieved the unrivalled status of Europe’s leading ElN forumthrough consistently delivering critical, timely and practical case studies, workshopsand discussion groups, as well as providing unparalleled networking opportunities forattendees and solution providers alike. Join us to celebrate 10 successful years!Over the past 9 years Pharma IQ’s ElNs forum has welcomed attendees fromthese companies: 4SC AG iNovacia Abbott Laboratories Institut de Recherches SERVIER Ablynx NV Ipsen Pharma SA Accelrys Ltd Janssen Pharmaceutica Country Total % ACRAF SpA Johnson & Johnson Actelion Pharmaceuticals Ltd. KineMatik Australia 1.60 Agilent Techniologies Laboratory Data Solutions ALK-Abelló LabWare Austria 1.60 Allergan Inc. LEK Pharmaceutical d.d. Belgium 11.20 Almirall Prodesfarma Research Centre LEO Pharma AS Amphora Research Systems LiPlasome Pharma A/S Denmark 12.80 Amsterdam Molecular Therapeutics (AMT) bv Lonza Group Ltd. France 8.00 Array BioPharma Inc L’Oreal Astellas L’Universite Libré de Bruxelles Germany 9.60 AstraZeneca Mars Asubio Pharma MedImmune Ltd. Ireland 0.80 Atrium Research Merck Italy 0.80 BASF Merz Pharma Basilea Pharmaceutica AG Metler Toledo Japan 2.40 Baxter Healthcare Corporation Metron Inc. Norway 0.80 Bayer Schering Pharma AG Millennium Pharmaceuticals Inc. Biogen Idec Mundi Pharma Research Spain 4.00 Biovitrum AB Nestlé Research Centre Sweden 3.20 Bistows Nofima Mat AS Boehringer Ingelheim Pharma GmbH & Co. KG Novartis International AG Switzerland 8.80 Bristol - Myers Squibb Novo Nordisk AS Cambridge University Novozymes AS The Netherlands 6.40 CambridgeSoft NV Organon United Kingdom 17.60 Carmeda AB Omnichem Centre for Ecology and Hydrology Oracle United States 10.40 ChemAxon Ltd Pfizer Ltd. Chiesi Farmaceutici SPA PhaseFour Informatics Chr Hansen AS Philip Morris International Cirrus Pharmaceuticals PRA International Concurrent Technologies Corporation Proskauer Rose LLP Contur Roche Diagnostics GmbH CSIRO Roche Palo Alto CSL Bioplasma Roche Products Ltd. Dow Corning Corp. Quattro Research e2v technologies Plc. SAFE BioPharma Association Eli Lilly and Company SAIC Elsevier Inc. Sanofi-Aventis eOrganized World Schering Plough Esteve Scientific Computing World Europa Science Ltd Siemens Evotec UK Solvay Pharmaceuticals BV F Hoffmann La Roche Ltd. STARLIMS FDA Swedish Prosecution Authority Ferring Symyx Job function Name Total % Galderma R&D Syngenta Crop Protection AG GE Healthcare AS Synthon BV IT, Informatics, Data Management, Genentech, Inc. Takeda Pharmaceutical Company ELN Project Managers & General Mills The Edge Software Consultancy System Architects 39.2 Genmab AS Thermo Fisher Scientific Genzyme Ltd. Thrombogenics NV Scientists 18.1 GeoMetrick Enterprises Thomson Reuters GGA Software Services Total Petrochemicals Research Feluy Business Analysts 11.2 GlaxoSmithKline UCB Celltech CIOs/ Senior Directors 9.6 Google UCB Pharma SA Grunenthal GmbH Unilever Plc. Industry Technology Providers 7.2 Henkel KgaA United States Patent and Trademark Office QA/ QC 7.2 Hoxie & Associates LLC University of Antwerp IDBS University of Cambridge Patent/ IP/ Regulatory 3.8 Incyte Corporation URGO Laboratories Infineum UK Ltd. Vernalis Consultants 2.5 InfoChem GmbH VIB Academics 1.2 Innogenetics NV Waters CALL: +44 (0)20 7368 9300 FAX: +44 (0)20 7368 9301 EMAIL: enquire@iqpc.co.uk VISIT: www.elnforum.com
    • 10th Annual 5 WAYS TO REGISTER Two Day Conference: 27th-28th September 2011 Freephone: 0800 652 2363 or Pre-Conference Focus Day & Workshops: +44 (0)20 7368 9300 26th September 2011 Fax: +44 (0)20 7368 9301 Venue: Hilton, Barcelona, Spain Post: your booking form to IQPC Ltd. To speed registration, please provide the priority code located on the mailing label or in the box below. 129 Wilton Road, My registration code is PDFW London SW1V 1JZ Please contact our database manager on +44(0) 207 368 9300 or at database@iqpc.co.uk quoting the registration Online: www.elnforum.com code above to inform us of any changes or to remove your details. Email: enquire@iqpc.co.uk Register and Register and Pay Register and Pay Standard PACKAGES Pay before before 27th May* before 1st July* Price 2nd September* Conference + Focus Day + 2 Workshops €4046+VAT €4096+VAT €4196+VAT €4,646+VAT Team Discounts* + Audio Recordings *** Save €600 Save €550 Save €450 IQPC recognises the value of learning in teams. Groups of 3 or more Conference + 2 Workshops €3297+VAT €3347+VAT €3447+VAT booking at the same time from the same company receive a 10% €3,747+VAT + Audio Recordings*** Save €450 Save €400 Save €300 discount. 5 or more receive a 15% discount. 7 receive a 20% discount. Conference + Focus Day + 1 Workshop ** €3497+VAT €3547+VAT €3647+VAT €3,997+VAT Only one discount available per person. + Audio Recordings*** Save €500 Save €450 Save €350 Conference + 1 Workshop** €2,748+VAT €2,798+VAT €2,898+VAT €3,098+VAT + Audio Recordings*** Conference + Focus Day Save €350 €2948+VAT Save €300 €2998+VAT Save €200 €3089+VAT Venue & Accommodation €3,348+VAT VENUE: Avda. Diagonal, 589-591, 08014 Barcelona Spain + Audio Recordings*** Save €400 Save €350 Save €250 Conference only €2149+VAT €2249+VAT €2349+VAT Tel: +34 93 495 77777 €2,449+VAT + Audio Recordings*** Save €300 Save €200 Save €100 ACCOMMODATION: Travel and accommodation are not included in the Focus Day Only €899+VAT €899+VAT €899+VAT €899+VAT registration fee, however, a number of discounted bedrooms have been reserved at the Hilton Barcelona Hotel. Please call the hotel directly on Workshop only [Each]** €649+VAT €649+VAT €649+VAT €649+VAT Tel: + 34 93 495 7777 and quote booking reference IQPC to receive your Audio recordings €550+VAT €550+VAT €550+VAT €550+VAT discounted rate, prices start from €160 including taxes and breakfast. There is limited availability and this is a very busy period in Barcelona so *All ‘Early Bird’ discounts must require payment at time of registration and before the cut-off date in order to receive any discount. we do encourage attendees to book early to avoid disappointment. Any discounts offered whether by (including team discounts) must also require payment at the time of registration. All discount offers cannot be combined with any other offer. **Please select you choice of workshop A 6 B 6 Free Online Resources ***Please tick if you wish to opt out for Audio Recordings (reducing the price by €550) All prices are subject to Spanish VAT at 18%. VAT Registration # N 006596 D To claim a variety of articles, podcasts and other free resources please visit www.elnforum.com Delegate Details Please photocopy for each additional delegate Digital Conference On CD-ROM 6 Mr 6 Mrs 6 Miss 6 Ms 6 Dr 6 Other A digital version of the conference proceedings, including all presentations, is available to buy. First Name Family Name 6 I cannot attend the event, please send me the CD Rom priced at Job Title £599 plus VAT Tel No. Recent digital conferences available - £599 plus VAT each Email 6 Yes I would like to receive information about products and services via email 6 9th Annual ELNs & Advanced Laboratory Solutions, September 2010 Organisation 6 6th Annual Smartlab Exchange, February-March 2011 Nature of business 6 Laboratory Data & Information Management Summit, May 2011 Address 6 Please send me conference materials indicated above. Postcode Country 6 I have filled out credit card details below Telephone Fax For further information Please call: 0207 368 9300 Approving Manager or email: knowledgebank@iqpc.co.uk. Name of person completing form if different from delegate: To search IQPC’s archived conference documentation visit: www.iqpcknowledgebank.com Signature I agree to IQPC’s cancellation, substitution and payment terms Special dietary requirements: 6 Vegetarian 6 Non-dairy 6 Other (please specify) Terms and Conditions Please indicate if you have already registered by Phone 6 Fax 6 Email 6 Web 6 Please read the information listed below as each booking is subject to IQPC Ltd standard terms and conditions. Return of this email will indicate that you accept these terms. Please note: if you have not received an acknowledgement before the conference, please call us to confirm your booking. Payment Terms: Upon completion and return of the registration form full payment is required no later than 5 business days from the date of invoice. Payment of invoices by means other than by credit card, or purchase order (UK Plc and UK government bodies only) will be subject to a €65 (plus VAT) per delegate processing fee. Payment Payment Method must be received prior to the conference date. We reserve the right to refuse admission to the conference if payment has not been received. IQPC Cancellation, Postponement and Substitution Policy: You may substitute delegates at any time by provid- Total price for your Organisation: (Add total of all individuals attending): ing reasonable advance notice to IQPC. For any cancellations received in writing not less than eight (8) days prior to the conference, you will receive a 90% Card Number: VISA 6 M/C 6 AMEX 6 credit to be used at another IQPC conference which must occur within one year from the date of issuance of such credit. An administration fee of 10% of the contract fee will be retained by IQPC for all permitted cancellations. No 6666666666666666 credit will be issued for any cancellations occurring within seven (7) days (inclusive) of the conference. In the event that IQPC cancels an event for any reason, you will receive a credit for 100% of the contract fee paid. Exp. Date: 6 6 6 6 Sec: 6 6 6 6 You may use this credit for another IQPC event to be mutually agreed with IQPC, which must occur within one yearConference code 11147.005 from the date of cancellation. In the event that IQPC postpones an event for any reason and the delegate is unable or unwilling to attend in on the rescheduled date, you will receive a credit for 100% of the contract fee paid. You may use this credit for another Name On Card: Signature: IQPC event to be mutually agreed with IQPC, which must occur within one year from the date of postponement. Except as specified above, no credits will be issued for cancellations. There are no refunds given under any circumstances. Billing Address (if different from below): IQPC is not responsible for any loss or damage as a result of a substitution, alteration or cancellation/postponement of an event. IQPC shall assume no liability whatsoever in the event this conference is cancelled, rescheduled or postponed due to a fortuitous event, Act of God, unforeseen occurrence or any other event that renders performance City/County/Postcode Cheque enclosed for: € (Made payable to IQPC Ltd.) of this conference impracticable, illegal or impossible. For purposes of this clause, a fortuitous event shall include, but not be limited to: war, fire, labour strike, extreme weather or other emergency. Please note that while speakers and topics were confirmed at the time of publishing, circumstances beyond the By Direct Transfer: (Please quote 11147.005 with remittance advice) IQPC Bank details: HSBC Bank, 67 George control of the organizers may necessitate substitutions, alterations or cancellations of the speakers and/or topics. As such, IQPC reserves the right to alter or modify the advertised speakers and/or topics if necessary without any Street, Richmond, Surrey, TW9 1HG Account No: 59090618 Sort Code: 40 05 15 Account No: 59090618 liability to you whatsoever. Any substitutions or alterations will be updated on our web page as soon as possible. IBAN Code: GB98 MIDL 4005 1559 0906 18 Swift Code: MIDLGB22 Discounts All ‘Early Bird’ Discounts require payment at time of registration and before the cut-off date in order to receive any discount. Any discounts offered whether by IQPC (including team discounts) must also require payment at the time of registration. All discount offers cannot be combined with any other offer PAYMENT MUST BE RECEIVED PRIOR TO THE CONFERENCE 6 Please do not pass my information to any third party